Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more
Huapont Life Sciences Co Ltd (002004) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.039x
Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) has a cash flow conversion efficiency ratio of 0.039x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥635.17 Million) by net assets (CN¥16.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Huapont Life Sciences Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Huapont Life Sciences Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Huapont Life Sciences Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huapont Life Sciences Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Staidson Beijing Biopharma
SHE:300204
|
-0.046x |
|
Mercialys
PINK:MEIYF
|
0.127x |
|
CRISIL Limited
NSE:CRISIL
|
0.073x |
|
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
|
0.048x |
|
MY EG Services Bhd
KLSE:0138
|
0.057x |
|
Ninety One Group
PINK:NINTF
|
-0.228x |
|
Guodian Nanjing Automation Co Ltd
SHG:600268
|
-0.064x |
|
Hong Leong Financial Group Bhd
KLSE:1082
|
0.055x |
Annual Cash Flow Conversion Efficiency for Huapont Life Sciences Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Huapont Life Sciences Co Ltd from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥15.47 Billion | CN¥1.63 Billion | 0.105x | +9.60% |
| 2023-12-31 | CN¥16.58 Billion | CN¥1.59 Billion | 0.096x | -34.12% |
| 2022-12-31 | CN¥16.55 Billion | CN¥2.41 Billion | 0.145x | +81.32% |
| 2021-12-31 | CN¥15.82 Billion | CN¥1.27 Billion | 0.080x | -52.20% |
| 2020-12-31 | CN¥14.14 Billion | CN¥2.37 Billion | 0.168x | +6.76% |
| 2019-12-31 | CN¥13.24 Billion | CN¥2.08 Billion | 0.157x | +5.02% |
| 2018-12-31 | CN¥12.75 Billion | CN¥1.91 Billion | 0.150x | +236.59% |
| 2017-12-31 | CN¥13.30 Billion | CN¥591.40 Million | 0.044x | -6.99% |
| 2016-12-31 | CN¥10.70 Billion | CN¥511.90 Million | 0.048x | +45.38% |
| 2015-12-31 | CN¥10.41 Billion | CN¥342.45 Million | 0.033x | -58.65% |
| 2014-12-31 | CN¥5.73 Billion | CN¥455.96 Million | 0.080x | -8.68% |
| 2013-12-31 | CN¥4.01 Billion | CN¥349.51 Million | 0.087x | -0.07% |
| 2012-12-31 | CN¥2.96 Billion | CN¥257.75 Million | 0.087x | +66.69% |
| 2011-12-31 | CN¥2.59 Billion | CN¥135.23 Million | 0.052x | -32.16% |
| 2010-12-31 | CN¥1.04 Billion | CN¥79.84 Million | 0.077x | -44.01% |
| 2009-12-31 | CN¥897.32 Million | CN¥123.53 Million | 0.138x | -1.49% |
| 2008-12-31 | CN¥814.07 Million | CN¥113.76 Million | 0.140x | +28.94% |
| 2007-12-31 | CN¥730.86 Million | CN¥79.21 Million | 0.108x | -14.27% |
| 2006-12-31 | CN¥522.90 Million | CN¥66.10 Million | 0.126x | +27.50% |
| 2005-12-31 | CN¥440.68 Million | CN¥43.69 Million | 0.099x | -43.60% |
| 2004-12-31 | CN¥401.64 Million | CN¥70.60 Million | 0.176x | -54.80% |
| 2003-12-31 | CN¥145.74 Million | CN¥56.68 Million | 0.389x | +7.74% |
| 2002-12-31 | CN¥102.18 Million | CN¥36.88 Million | 0.361x | -- |